Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1934 1
1938 1
1939 1
1949 1
1952 1
1956 5
1957 3
1958 2
1959 3
1960 2
1961 4
1962 5
1963 9
1964 10
1965 13
1966 8
1967 8
1968 7
1969 13
1970 8
1971 10
1972 7
1973 4
1974 5
1975 2
1976 9
1977 13
1978 14
1979 19
1980 28
1981 40
1982 30
1983 21
1984 29
1985 46
1986 45
1987 45
1988 36
1989 30
1990 35
1991 28
1992 40
1993 34
1994 43
1995 54
1996 44
1997 53
1998 47
1999 52
2000 56
2001 53
2002 68
2003 70
2004 81
2005 80
2006 82
2007 85
2008 97
2009 128
2010 143
2011 146
2012 211
2013 261
2014 251
2015 294
2016 297
2017 320
2018 294
2019 359
2020 412
2021 499
2022 532
2023 485
2024 232

Text availability

Article attribute

Article type

Publication date

Search Results

5,874 results

Results by year

Filters applied: . Clear all
Page 1
Human cerebellar organoids with functional Purkinje cells.
Atamian A, Birtele M, Hosseini N, Nguyen T, Seth A, Del Dosso A, Paul S, Tedeschi N, Taylor R, Coba MP, Samarasinghe R, Lois C, Quadrato G. Atamian A, et al. Among authors: paul s. Cell Stem Cell. 2024 Jan 4;31(1):39-51.e6. doi: 10.1016/j.stem.2023.11.013. Cell Stem Cell. 2024. PMID: 38181749
Efficacy and safety of the muscarinic receptor agonist KarXT (xanomeline-trospium) in schizophrenia (EMERGENT-2) in the USA: results from a randomised, double-blind, placebo-controlled, flexible-dose phase 3 trial.
Kaul I, Sawchak S, Correll CU, Kakar R, Breier A, Zhu H, Miller AC, Paul SM, Brannan SK. Kaul I, et al. Among authors: paul sm. Lancet. 2024 Jan 13;403(10422):160-170. doi: 10.1016/S0140-6736(23)02190-6. Epub 2023 Dec 14. Lancet. 2024. PMID: 38104575 Clinical Trial.
MicroRNA Theranostics in Cancer.
Paul S. Paul S. Curr Gene Ther. 2023;23(5):329. doi: 10.2174/156652322305230808102847. Curr Gene Ther. 2023. PMID: 37728083 No abstract available.
TRBC1-targeting antibody-drug conjugates for the treatment of T cell cancers.
Nichakawade TD, Ge J, Mog BJ, Lee BS, Pearlman AH, Hwang MS, DiNapoli SR, Wyhs N, Marcou N, Glavaris S, Konig MF, Gabelli SB, Watson E, Sterling C, Wagner-Johnston N, Rozati S, Swinnen L, Fuchs E, Pardoll DM, Gabrielson K, Papadopoulos N, Bettegowda C, Kinzler KW, Zhou S, Sur S, Vogelstein B, Paul S. Nichakawade TD, et al. Among authors: paul s. Nature. 2024 Apr;628(8007):416-423. doi: 10.1038/s41586-024-07233-2. Epub 2024 Mar 27. Nature. 2024. PMID: 38538786
Results of salvage therapy with mini-hyper-CVD and inotuzumab ozogamicin with or without blinatumomab in pre-B acute lymphoblastic leukemia.
Kantarjian H, Haddad FG, Jain N, Sasaki K, Short NJ, Loghavi S, Kanagal-Shamanna R, Jorgensen J, Khouri I, Kebriaei P, Alvarado Y, Kadia T, Paul S, Garcia-Manero G, Dabaja B, Yilmaz M, Jacob J, Garris R, O'Brien S, Ravandi F, Jabbour E. Kantarjian H, et al. Among authors: paul s. J Hematol Oncol. 2023 May 2;16(1):44. doi: 10.1186/s13045-023-01444-2. J Hematol Oncol. 2023. PMID: 37131217 Free PMC article. Clinical Trial.
Focused Ultrasound for Dermal Applications.
Al-Jumaily AM, Liaquat H, Paul S. Al-Jumaily AM, et al. Among authors: paul s. Ultrasound Med Biol. 2024 Jan;50(1):8-17. doi: 10.1016/j.ultrasmedbio.2023.09.004. Epub 2023 Oct 7. Ultrasound Med Biol. 2024. PMID: 37806924 Review.
Hydatid Disease of the Liver.
Bhalla VP, Paul S, Klar E. Bhalla VP, et al. Among authors: paul s. Visc Med. 2023 Oct;39(5):112-120. doi: 10.1159/000533807. Epub 2023 Sep 25. Visc Med. 2023. PMID: 37899792 Review.
5,874 results